Xeris Pharmaceuticals | XERS - 流動負債

株価
6.05
毎日の変更
0.10 1.68%
毎月
14.15%
毎年
40.37%
Q2 予測
5.92




流動負債 変化する 日付
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pharma Mar EUR 93.88M 4.94M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09